Allianz Nears a Decisive Technical Test as Caravela Deal Targets 7% Portugal Market Share

Allianz shares have crept to €381.10, just over 4% below the 52-week high of €397 set in late April, as investors weigh a potential Portuguese acquisition that could redraw the group’s Iberian footprint. Wednesday’s 2% gain lifted the stock above all three key moving averages for the first time in weeks, but the narrow margin — barely 0.34% above the 50-day line at €379.82 — leaves the rally vulnerable to a sudden reversal.

Behind the price action, Allianz is in advanced talks to buy Lisbon-based non-life insurer Caravela Seguros. The deal would vault the German group’s Portuguese market share from 1.3% to roughly 6.8% in total premiums, and to around 11% in the property-and-casualty segment on a pro-forma basis using 2025 figures. Caravela booked premium income of €212 million last year, up from €187 million the year before, and a combined entity would generate over €1.15 billion in common premiums. The acquisition would transform Allianz from a marginal player into a meaningful competitor in the Portuguese insurance market.

The firepower for such a move comes from a first quarter that delivered a record operating profit of €4.5 billion. Solvency improved to 221%, giving management plenty of capacity to pursue inorganic growth while simultaneously running a multi-billion-euro share buyback programme that is scheduled to conclude in December 2026. Allianz Global Investors, the group’s asset management arm, is meanwhile also planning an Asian expansion, signalling a multi-front growth push.

Should investors sell immediately? Or is it worth buying Allianz?

Technically, the stock occupies a constructive but delicate position. The 50-day moving average sits at €379.82, the 100-day at €373.66, and the 200-day at €370.56 — all below the current price. The relative strength index at 52 places the shares firmly in neutral territory, indicating the recent advance is not overstretched. Annualised 30-day volatility of 24.34% is elevated for a €141 billion insurer but not exceptional given the corporate activity.

The hard ceiling remains the 52-week high of €397.00 from 21 April. A sustained breakout above that level would decisively improve the chart, while on the downside, successive supports lie at the 100- and 200-day averages. A loss of the 200-day line would darken the medium-term picture. For now, the stock is up about 2% on the day but still shows a year-to-date decline of roughly 2%.

With second-quarter results due in August and the Caravela negotiations at an advanced stage, the next few weeks could supply either the technical catalyst needed to test €397 or a setback that forces a retest of the moving averages. The confluence of a record profit base, a clear acquisition target, and a low-momentum technical setup leaves Allianz’s direction firmly in the hands of deal news and macro sentiment.

Ad

Allianz Stock: New Analysis - 9 June

Fresh Allianz information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Allianz analysis...

en | DE0008404005 | ALLIANZ | boerse | 69507275 |